Get started
Saniona ABSaniona ABSaniona AB

Saniona AB

No trades
See on Supercharts
Overview
Financials News Discussions Seasonals

30S chart


Full chart

30S upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪165.30 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
6.500
Basic EPS (TTM)
0.174 EUR
Net income (FY)
‪16.41 M‬ EUR
Revenue (FY)
‪29.10 M‬ EUR
Shares float
‪120.89 M‬
Beta (1Y)
−0.19

Employees


Employees (FY)
22
Change (1Y)
−1 −4.35%
Revenue / Employee (1Y)
—
Net income / Employee (1Y)
—

About Saniona AB


Sector
Health Technology
Industry
Biotechnology
CEO
Thomas Feldthus
Website
saniona.com
Headquarters
Glostrup
Founded
2014
ISIN
SE0005794617
FIGI
BBG00F15VYG7
Saniona AB engages in the research and development on drugs for diseases of the central nervous system, autoimmune diseases, and metabolic diseases. Its research focuses on ion channels, which make up of protein that enables and controls the passage of charged ions across cell membranes. Its product pipeline includes Tesofensine, Tesomet, SAN711, and SAN903. The company was founded by Claus Tycho Bræstrup, Anker Gunvald Lundemose, Jørgen Drejer, Palle Christophersen, and Thomas Feldthus in 2011 and is headquartered Glostrup, Denmark.

Check out other big names from the same industry as 30S.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

30S news



Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Saniona AB stocks are traded under the ticker 30S.
30S reached its all-time high on Aug 12, 2020 with the price of 4.260 EUR, and its all-time low was 0.120 EUR and was reached on May 3, 2024. View more price dynamics on 30S chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Saniona AB financials in yearly and quarterly reports right on TradingView.
Saniona AB is going to release the next earnings report on Nov 27, 2025. Keep track of upcoming events with our Earnings Calendar.
30S net income for the last quarter is ‪−1.99 M‬ EUR, while the quarter before that showed ‪1.74 M‬ EUR of net income which accounts for −214.26% change. Track more Saniona AB financial stats to get the full picture.
No, 30S doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 7, 2025, the company has 22 employees. See our rating of the largest employees — is Saniona AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Saniona AB EBITDA is ‪21.08 M‬ EUR, and current EBITDA margin is 73.74%. See more stats in Saniona AB financial statements.
Like other stocks, 30S shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Saniona AB stock right from TradingView charts — choose your broker and connect to your account.